Paul Knight
Stock Analyst at Keybanc
(2.40)
# 2,557
Out of 4,996 analysts
137
Total ratings
47.79%
Success rate
-1.72%
Average return
Main Sectors:
Stocks Rated by Paul Knight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LFCR Lifecore Biomedical | Initiates: Sector Weight | n/a | $7.01 | - | 1 | Sep 4, 2025 | |
| ATR AptarGroup | Initiates: Overweight | $220 | $132.29 | +66.30% | 1 | Sep 4, 2025 | |
| CYRX Cryoport | Upgrades: Overweight | $15 | $9.20 | +63.04% | 9 | Aug 6, 2025 | |
| XGN Exagen | Upgrades: Overweight | $17 | $10.89 | +56.11% | 6 | Jul 30, 2025 | |
| EHC Encompass Health | Maintains: Overweight | $122 → $135 | $126.70 | +6.55% | 1 | May 27, 2025 | |
| HBIO Harvard Bioscience | Downgrades: Sector Weight | n/a | $0.44 | - | 5 | Apr 9, 2025 | |
| TECH Bio-Techne | Downgrades: Sector Weight | n/a | $51.84 | - | 9 | Apr 9, 2025 | |
| WAT Waters | Upgrades: Overweight | $460 | $291.71 | +57.69% | 5 | Mar 31, 2025 | |
| LAB Standard BioTools | Downgrades: Sector Weight | n/a | $1.30 | - | 2 | Feb 27, 2025 | |
| WST West Pharmaceutical Services | Maintains: Overweight | $470 → $325 | $261.52 | +24.27% | 11 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $8 | $3.27 | +144.65% | 1 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $132 → $145 | $84.06 | +72.50% | 3 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $420 | $176.30 | +138.23% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $213 → $230 | $105.77 | +117.45% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $33 | $24.70 | +33.60% | 5 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $36 | $22.71 | +58.52% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $310 | $184.84 | +67.71% | 9 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $210 → $220 | $125.61 | +75.15% | 7 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $464.24 | - | 6 | Oct 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $35 → $37 | $25.66 | +44.19% | 5 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $2.82 | - | 8 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $6.07 | - | 1 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $123.39 | - | 8 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $28.54 | - | 3 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $51 → $40 | $11.84 | +237.84% | 6 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $390 → $300 | $148.56 | +101.94% | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $250 | $179.56 | +39.23% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $382 → $441 | $119.99 | +267.53% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $222 → $236 | $118.81 | +98.64% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $92 → $99 | $67.55 | +46.56% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $47 → $55 | $11.77 | +367.29% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $33.44 | - | 4 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $64.51 | - | 1 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $91.69 | - | 5 | Oct 23, 2017 |
Lifecore Biomedical
Sep 4, 2025
Initiates: Sector Weight
Price Target: n/a
Current: $7.01
Upside: -
AptarGroup
Sep 4, 2025
Initiates: Overweight
Price Target: $220
Current: $132.29
Upside: +66.30%
Cryoport
Aug 6, 2025
Upgrades: Overweight
Price Target: $15
Current: $9.20
Upside: +63.04%
Exagen
Jul 30, 2025
Upgrades: Overweight
Price Target: $17
Current: $10.89
Upside: +56.11%
Encompass Health
May 27, 2025
Maintains: Overweight
Price Target: $122 → $135
Current: $126.70
Upside: +6.55%
Harvard Bioscience
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $0.44
Upside: -
Bio-Techne
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $51.84
Upside: -
Waters
Mar 31, 2025
Upgrades: Overweight
Price Target: $460
Current: $291.71
Upside: +57.69%
Standard BioTools
Feb 27, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $1.30
Upside: -
West Pharmaceutical Services
Feb 14, 2025
Maintains: Overweight
Price Target: $470 → $325
Current: $261.52
Upside: +24.27%
Feb 12, 2025
Initiates: Overweight
Price Target: $8
Current: $3.27
Upside: +144.65%
Feb 3, 2025
Maintains: Overweight
Price Target: $132 → $145
Current: $84.06
Upside: +72.50%
Jan 23, 2025
Maintains: Overweight
Price Target: $400 → $420
Current: $176.30
Upside: +138.23%
Jan 23, 2025
Maintains: Overweight
Price Target: $213 → $230
Current: $105.77
Upside: +117.45%
Dec 13, 2024
Maintains: Overweight
Price Target: $30 → $33
Current: $24.70
Upside: +33.60%
Nov 5, 2024
Maintains: Overweight
Price Target: $28 → $36
Current: $22.71
Upside: +58.52%
Oct 23, 2024
Maintains: Overweight
Price Target: $290 → $310
Current: $184.84
Upside: +67.71%
Feb 15, 2024
Maintains: Overweight
Price Target: $210 → $220
Current: $125.61
Upside: +75.15%
Oct 26, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $464.24
Upside: -
Aug 30, 2023
Maintains: Overweight
Price Target: $35 → $37
Current: $25.66
Upside: +44.19%
Aug 8, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $2.82
Upside: -
Jul 12, 2023
Initiates: Sector Weight
Price Target: n/a
Current: $6.07
Upside: -
May 24, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $123.39
Upside: -
May 10, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $28.54
Upside: -
Sep 15, 2022
Maintains: Overweight
Price Target: $51 → $40
Current: $11.84
Upside: +237.84%
May 5, 2022
Maintains: Overweight
Price Target: $390 → $300
Current: $148.56
Upside: +101.94%
Apr 28, 2022
Maintains: Overweight
Price Target: $290 → $250
Current: $179.56
Upside: +39.23%
Jan 8, 2021
Maintains: Overweight
Price Target: $382 → $441
Current: $119.99
Upside: +267.53%
Jan 8, 2021
Maintains: Overweight
Price Target: $222 → $236
Current: $118.81
Upside: +98.64%
Jan 8, 2021
Maintains: Overweight
Price Target: $92 → $99
Current: $67.55
Upside: +46.56%
Jan 8, 2021
Maintains: Overweight
Price Target: $47 → $55
Current: $11.77
Upside: +367.29%
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $33.44
Upside: -
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $64.51
Upside: -
Oct 23, 2017
Upgrades: Neutral
Price Target: n/a
Current: $91.69
Upside: -